Edition:
United Kingdom

Keryx Biopharmaceuticals Inc (KERX.OQ)

KERX.OQ on NASDAQ Stock Exchange Capital Market

5.20USD
18 May 2018
Change (% chg)

$-0.46 (-8.13%)
Prev Close
$5.66
Open
$5.68
Day's High
$5.70
Day's Low
$5.18
Volume
359,189
Avg. Vol
305,892
52-wk High
$8.37
52-wk Low
$3.92

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 21.75 -0.183
FY 2017 Dec '17 18.68 -1.192
Sep '17 15.00 -0.197
Jun '17 15.14 -0.768
Mar '17 11.82 -0.215
FY 2016 Dec '16 9.53 -0.319
Sep '16 6.34 -0.394
Jun '16 9.29 -0.422
Mar '16 6.82 -0.388
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 5 24.74 25.61 23.09 28.05
Quarter Ending Sep-18 5 28.31 29.94 25.02 30.90
Year Ending Dec-18 5 106.82 111.30 95.84 129.02
Year Ending Dec-19 7 173.24 239.70 128.70 194.21
Earnings (per share)
Quarter Ending Jun-18 6 -0.16 -0.13 -0.18 -0.08
Quarter Ending Sep-18 6 -0.13 -0.09 -0.15 -0.06
Year Ending Dec-18 5 -0.58 -0.50 -0.65 -0.23
Year Ending Dec-19 8 -0.16 0.14 -0.32 0.07
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 223.30 32.53
P/E High - Last 5 Yrs. -- 281.11 47.11
P/E Low - Last 5 Yrs. -- 95.06 24.61
Beta 2.63 0.75 0.79
Price to Sales (TTM) 9.56 261.80 8.85
Price to Book (MRQ) -- 23.37 4.22
Price to Tangible Book (MRQ) -- 26.33 5.79
Price to Cash Flow (TTM) -- 127.56 21.98
% Owned Institutions 65.16 10.86 2.39

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.67
Dividend Yield - 5 Year Avg -- 0.21 0.80
Dividend 5 Year Growth Rate -- 2.34 4.12
Payout Ratio(TTM) -- 47.06 17.66

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 84.03 26.67 5.06
Sales (TTM) vs TTM 1 Yr. Ago 90.86 146.75 12.43
Sales - 5 Yr. Growth Rate -- 30.07 8.11
EPS (MRQ) vs Qtr. 1 Yr. Ago 15.01 -162.81 32.52
EPS (TTM) vs TTM 1 Yr. Ago -73.45 -- --
EPS - 5 Yr. Growth Rate -- 46.61 8.54
Capital Spending - 5 Yr. Growth Rate 120.71 38.65 8.79

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.87 1.65 2.50
Current Ratio (MRQ) 2.66 6.55 3.56
LT Debt to Equity (MRQ) -- 22.13 12.76
Total Debt to Equity (MRQ) -- 25.64 15.69
Interest Coverage (TTM) -58.38 -185.60 34.90

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 57.14 32.90 54.71
Gross Margin - 5 Yr. Avg. -- 54.92 52.74
EBITD Margin (TTM) -142.23 -- --
EBITD - 5 Yr. Avg -395.50 -155.94 15.91
Operating Margin (TTM) -143.59 -929.27 -1.83
Operating Margin - 5 Yr. Avg. -397.84 -168.52 11.18
Pre-Tax Margin (TTM) -231.26 -813.68 0.25
Pre-Tax Margin - 5 Yr. Avg. -487.63 -174.04 11.38
Net Profit Margin (TTM) -388.28 -804.80 -3.16
Net Profit Margin - 5 Yr. Avg. -578.13 -173.41 7.67
Effective Tax Rate (TTM) -- 14.53 31.64
Effective Tax Rate - 5 Yr. Avg. -- 18.17 24.59

Efficiency

  Company industry sector
Revenue/Employee (TTM) 336,062 21,415,270 726,901,196
Net Income/Employee (TTM) -1,304,857 -1,532,715 84,519,443
Receivable Turnover (TTM) 7.41 16.37 5.67
Inventory Turnover (TTM) 1.26 2.45 3.53
Asset Turnover (TTM) 0.53 0.42 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -204.63 -5.67 9.99
Return on Assets - 5 Yr. Avg. -109.86 -0.55 11.11
Return on Investment (TTM) -272.96 -8.07 12.63
Return on Investment - 5 Yr. Avg. -148.67 2.59 14.39
Return on Equity (TTM) -- -10.87 14.50
Return on Equity - 5 Yr. Avg. -366.66 -2.77 15.75
  1 Year 3 Year 5 Year
Sales % 89.60 77.60 --
EPS (TTM) % -57.87 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Keryx Biopharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 65.02%
# of Holders: 174
Total Shares Held: 78,310,551
3 Mo. Net Change: -1,406,910
# New Positions: 15
# Closed Positions: 22
# Increased Positions: 60
# Reduced Positions: 73
# Net Buyers: -13
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.